Health
Full intensity heparin has value in treating hospitalized COVID-19 patients – News-Medical.Net
Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin…
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers led by Peter Jüni of St. Michael’s Hospital and the University…
Continue Reading
-
Noosa News20 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General19 hours agoParis opens River Seine for public swimming for first time since 1923
-
Noosa News12 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News5 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland